Sign In
Buy MSFT
$499.99
+0.130 (+0.0260%)
At Close: Aug 07, 2026
If You Buy 2 Tech Stocks This Year, Make Them These
01:39pm, Tuesday, 17'th Mar 2026
Tech stocks as a class are down by about 5% this year. Microsoft is trading at 24 times forward earnings.
Microsoft revamps Copilot structure, elevating former Snap exec as Suleyman shifts to AI models
01:00pm, Tuesday, 17'th Mar 2026
Microsoft is reorganizing its Copilot organization, unifying its consumer and commercial AI efforts under former Snap executive Jacob Andreou while narrowing the role of Microsoft AI leader Mustafa Su
Microsoft unifies Copilot commercial and consumer product teams in unit rejig
11:24am, Tuesday, 17'th Mar 2026
Microsoft said on Tuesday it is reorganizing its Copilot AI product teams by unifying its commercial and consumer versions, as the tech giant rushes to improve its AI assistant pr
Microsoft shakes up Copilot AI leadership team, freeing up Suleyman
11:16am, Tuesday, 17'th Mar 2026
Former Snap executive Jacob Andreou will be in charge of the Copilot artificial intelligence assistant experience for commercial and consumer clients, Microsoft CEO Satya Nadella said in a memo. Musta
Microsoft Seeks More Coherence in AI Efforts With Copilot Reorganization
11:00am, Tuesday, 17'th Mar 2026
The software giant is scrapping the divide between the consumer and business app teams.
Why Microsoft (MSFT) is a Top Stock for the Long-Term
10:31am, Tuesday, 17'th Mar 2026
The Zacks Focus List offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.
Zenity Announces Availability of Inline Agent Runtime Security for Agents Built on Microsoft Foundry
09:02am, Tuesday, 17'th Mar 2026
NEW YORK--(BUSINESS WIRE)-- #AIAgentSecuritySummit--Zenity announces the availability of runtime security controls for AI agents built on Microsoft Foundry as part of a partnership with Microsoft.
Microsoft's New $99 Copilot Tier Points to a High-Stakes AI Monetization Push
09:00am, Tuesday, 17'th Mar 2026
Microsoft is increasing the price of its highest-priced enterprise tier by 65%. The company is trying to boost AI revenue after a massive run-up in infrastructure spending.
Elon Musk Says Potential Proceeds Of OpenAI Lawsuit Will Go To Charity— 'I Will In No Way Enrich Myself'
05:13am, Tuesday, 17'th Mar 2026
The richest man in the world, Elon Musk, declared that any legal victory in his ongoing case against OpenAI will be donated to charity, emphasizing his non-profit intentions.
Bollard Group LLC Increases Position in Microsoft Corporation $MSFT
03:45am, Tuesday, 17'th Mar 2026
Bollard Group LLC raised its stake in shares of Microsoft Corporation (NASDAQ: MSFT) by 2.4% in the third quarter, according to its most recent 13F filing with the SEC. The fund owned 322,656 shares o
BlueSpruce Investments LP Has $793.49 Million Stake in Microsoft Corporation $MSFT
03:45am, Tuesday, 17'th Mar 2026
BlueSpruce Investments LP lifted its stake in Microsoft Corporation (NASDAQ: MSFT) by 14.2% in the third quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 1,
The Best Stocks to Buy With $1,000 Right Now
12:00am, Tuesday, 17'th Mar 2026
The market is only valuing Nvidia's stock as it will grow for one more year. Microsoft has seldom been this cheap over the past decade.
The Stocks Goldman Sachs Thinks You Should Own as Iran War Stretches Into a Third Week
08:00pm, Monday, 16'th Mar 2026
The stock market will likely weather the fallout from conflict in the Middle East, but rising oil prices could generate headwinds for the stocks that Goldman Sachs expected to benefit from acceleratin
Nebius Group specializes in designing data centers optimized for artificial intelligence (AI) training and inference. Nebius has won tens of billions of dollars worth of capacity agreements with multi
Elon Musk Wins Ruling $134 Billion Fraud Trial Against OpenAI, But Will He Win The Trial?
03:34pm, Monday, 16'th Mar 2026
Elon Musk wins ruling barring OpenAI from questioning his alleged ketamine use during upcoming trial. Trial expected to last 4 weeks.
